Takeda Pharmaceutical Company Limited announced that its Board of Directors resolved to engage in the acquisition of its own shares pursuant to the provision of its Articles of Incorporation in accordance with Article 459, paragraph 1 of the Companies Act of Japan, as detailed below.
October 28, 2021
· 7 min read